Scientific guidance on post-authorisation efficacy studies

Current effective version

PDF iconAdopted guideline

Reference numberEMA/PDCO/CAT/CMDh/PRAC/CHMP/261500/2015
Effective from01/06/2017
KeywordsPost-authorisation efficacy studies (PAES), efficacy, observational, randomised, trials pragmatic, explanatory, historical controls
DescriptionThis guidance has been developed in accordance with Article 108a of Directive 2001/83/EC which provides a mandate for European Medicines Agency (EMA) in cooperation with competent authorities and other interested parties to draw up scientific guidance on PAES.

Document history

First version
Current version

PDF iconAdopted guideline

Overview of comments

PDF iconDraft guideline

In operation: 01/06/2017-present

Published: 20/12/2016

Published: 06/11/2015

Related content

How useful was this page?

Add your rating